Found: 70
Select item for more details and to access through your institution.
Azole Resistance of Aspergillus fumigatus in Immunocompromised Patients with Invasive Aspergillosis.
- Published in:
- 2016
- By:
- Publication type:
- commentary
Biallelic inactivation of REV7 is associated with Fanconi anemia.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Moving toward Individual Treatment Goals with Pegcetacoplan in Patients with PNH and Impaired Bone Marrow Function.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 16, p. 8591, doi. 10.3390/ijms25168591
- By:
- Publication type:
- Article
Comparable relapse incidence after unrelated allogeneic stem cell transplantation with post‐transplant cyclophosphamide versus conventional anti‐graft versus host disease prophylaxis in patients with acute myeloid leukemia: A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 9, p. 1732, doi. 10.1002/ajh.27383
- By:
- Publication type:
- Article
Peripheral blood stem cell versus bone marrow graft for patients ≥60 years undergoing reduced intensity conditioning haploidentical transplantation for acute myeloid leukemia in complete remission: An analysis of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 7, p. 1250, doi. 10.1002/ajh.27343
- By:
- Publication type:
- Article
Impact of comorbidities and body mass index on the outcomes of allogeneic hematopoietic cell transplantation in myelofibrosis: A study on behalf of the Chronic Malignancies Working Party of EBMT.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 5, p. 993, doi. 10.1002/ajh.27262
- By:
- Publication type:
- Article
Systemic complement activation influences outcomes after allogeneic hematopoietic cell transplantation: A prospective French multicenter trial.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 10, p. 1559, doi. 10.1002/ajh.27030
- By:
- Publication type:
- Article
Complement inhibition in medicine: Hematology and beyond; complement inhibition in hematology: PNH and beyond.
- Published in:
- American Journal of Hematology, 2023, v. 98, p. S3, doi. 10.1002/ajh.26912
- By:
- Publication type:
- Article
Upfront unrelated donor hematopoietic stem cell transplantation in patients with idiopathic aplastic anemia: A retrospective study of the Severe Aplastic Anemia Working Party of European Bone Marrow Transplantation.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 1, p. E1, doi. 10.1002/ajh.26354
- By:
- Publication type:
- Article
Effectiveness of eculizumab in patients with paroxysmal nocturnal hemoglobinuria (PNH) with or without aplastic anemia in the International PNH Registry.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 1, p. E37, doi. 10.1002/ajh.25334
- By:
- Publication type:
- Article
Nationwide survey on the use of horse antithymocyte globulins (ATGAM) in patients with acquired aplastic anemia: A report on behalf of the French Reference Center for Aplastic Anemia.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 5, p. 635, doi. 10.1002/ajh.25050
- By:
- Publication type:
- Article
Impact of the source of hematopoietic stem cell in unrelated transplants: Comparison between 10/10, 9/10- HLA matched donors and cord blood.
- Published in:
- American Journal of Hematology, 2015, v. 90, n. 10, p. 897, doi. 10.1002/ajh.24112
- By:
- Publication type:
- Article
EF/SSc overlap syndrome and aplastic anaemia resistant to immunosuppressive therapy.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
EF/SSc overlap syndrome and aplastic anaemia resistant to immunosuppressive therapy.
- Published in:
- Rheumatology, 2012, v. 51, n. 4, p. 762, doi. 10.1093/rheumatology/ker406
- By:
- Publication type:
- Article
Long‐term safety and efficacy of ravulizumab in patients with paroxysmal nocturnal hemoglobinuria: 2‐year results from two pivotal phase 3 studies.
- Published in:
- European Journal of Haematology, 2022, v. 109, n. 3, p. 205, doi. 10.1111/ejh.13783
- By:
- Publication type:
- Article
One‐year outcomes from a phase 3 randomized trial of ravulizumab in adults with paroxysmal nocturnal hemoglobinuria who received prior eculizumab.
- Published in:
- European Journal of Haematology, 2021, v. 106, n. 3, p. 389, doi. 10.1111/ejh.13564
- By:
- Publication type:
- Article
Alemtuzumab vs anti‐thymocyte globulin in patients transplanted from an unrelated donor after a reduced intensity conditioning.
- Published in:
- European Journal of Haematology, 2018, v. 101, n. 4, p. 466, doi. 10.1111/ejh.13085
- By:
- Publication type:
- Article
Polyomaviruses KI and WU in Immuno-compromised Patients with Respiratory Disease.
- Published in:
- Emerging Infectious Diseases, 2009, v. 15, n. 1, p. 107, doi. 10.3201/1501.080758
- By:
- Publication type:
- Article
CT-118: PH3 Study of Efficacy and Safety of Iptacopan (LNP023), an Oral Complement Factor B Inhibitor, in Patients with Paroxysmal Nocturnal Hemoglobinuria and Residual Anemia Despite Anti-C5 Antibody Treatment.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S449, doi. 10.1016/S2152-2650(21)01998-4
- By:
- Publication type:
- Article
CT-121: Phase 3 Study of the Efficacy and Safety of Iptacopan (LNP023), an Oral Factor B Inhibitor, in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Naïve to Complement Inhibitor Therapy.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S450, doi. 10.1016/S2152-2650(21)01999-6
- By:
- Publication type:
- Article
MDS-134: Efficacy and Safety at 48 Weeks of Pegcetacoplan in Adult Paroxysmal Nocturnal Hemoglobinuria Patients with Suboptimal Response to Prior Eculizumab Treatment.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S341, doi. 10.1016/S2152-2650(21)01795-X
- By:
- Publication type:
- Article
MDS-126: Categorized Hematologic Response to Pegcetacoplan in Patients with Paroxysmal Nocturnal Hemoglobinuria: Post Hoc Analysis of Data from Phase 1b (PADDOCK) and Phase 2a (PALOMINO) Trials.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S340, doi. 10.1016/S2152-2650(21)01793-6
- By:
- Publication type:
- Article
Poster: CT-121: Phase 3 Study of the Efficacy and Safety of Iptacopan (LNP023), an Oral Factor B Inhibitor, in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Naïve to Complement Inhibitor Therapy.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S259, doi. 10.1016/S2152-2650(21)01636-0
- By:
- Publication type:
- Article
Poster: CT-118: PH3 Study of Efficacy and Safety of Iptacopan (LNP023), an Oral Complement Factor B Inhibitor, in Patients with Paroxysmal Nocturnal Hemoglobinuria and Residual Anemia Despite Anti-C5 Antibody Treatment.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S259, doi. 10.1016/S2152-2650(21)01635-9
- By:
- Publication type:
- Article
Poster: MDS-134: Efficacy and Safety at 48 Weeks of Pegcetacoplan in Adult Paroxysmal Nocturnal Hemoglobinuria Patients with Suboptimal Response to Prior Eculizumab Treatment.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S228, doi. 10.1016/S2152-2650(21)01438-5
- By:
- Publication type:
- Article
Poster: MDS-126: Categorized Hematologic Response to Pegcetacoplan in Patients with Paroxysmal Nocturnal Hemoglobinuria: Post Hoc Analysis of Data from Phase 1b (PADDOCK) and Phase 2a (PALOMINO) Trials.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S228, doi. 10.1016/S2152-2650(21)01437-3
- By:
- Publication type:
- Article
Association of Matched Sibling Donor Hematopoietic Stem Cell Transplantation With Transcranial Doppler Velocities in Children With Sickle Cell Anemia.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Improvements in hematologic markers and decreases in fatigue with pegcetacoplan for patients with paroxysmal nocturnal hemoglobinuria and mild or moderate anemia (hemoglobin ≥10 g/dL) who had received eculizumab or were naive to complement inhibitors
- Published in:
- PLoS ONE, 2024, v. 19, n. 7, p. 1, doi. 10.1371/journal.pone.0306407
- By:
- Publication type:
- Article
Safety and Efficacy of Pegcetacoplan in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria over 48 Weeks: 307 Open-Label Extension Study.
- Published in:
- Advances in Therapy, 2024, v. 41, n. 5, p. 2050, doi. 10.1007/s12325-024-02827-8
- By:
- Publication type:
- Article
"CRYOSTEM Biobank: A National Prospective, Standardized Collection to Better Characterize Allogeneic Hematopoietic Stem Cell Transplantation Complications".
- Published in:
- Open Journal of Bioresources, 2020, v. 7, n. 4-6, p. 1, doi. 10.5334/ojb.58
- By:
- Publication type:
- Article
Dermatopulmonary Syndrome Associated With Anti-MDA5 Antibodies After Allogeneic Hematopoietic Stem Cell Transplantation.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Antiphospholipid antibodies in patients with paroxysmal nocturnal haemoglobinuria receiving eculizumab.
- Published in:
- British Journal of Haematology, 2011, v. 153, n. 6, p. 789, doi. 10.1111/j.1365-2141.2011.08665.x
- By:
- Publication type:
- Article
Splenectomy after allogeneic haematopoietic stem cell transplantation in patients with primary myelofibrosis.
- Published in:
- 2010
- By:
- Publication type:
- Letter
Coeliac disease and aplastic anaemia: a specific entity?
- Published in:
- 2009
- By:
- Publication type:
- Letter
Influence of bone marrow graft B lymphocyte subsets on outcome after HLA-identical sibling transplants.
- Published in:
- British Journal of Haematology, 2009, v. 145, n. 1, p. 107, doi. 10.1111/j.1365-2141.2008.07574.x
- By:
- Publication type:
- Article
Influence of bone marrow nucleated red blood cell dose on outcome after allogeneic haematopoietic stem cell transplantation.
- Published in:
- 2008
- By:
- Publication type:
- Letter
Second transplant with two unrelated cord blood units for early graft failure after haematopoietic stem cell transplantation.
- Published in:
- British Journal of Haematology, 2007, v. 137, n. 3, p. 248, doi. 10.1111/j.1365-2141.2007.06562.x
- By:
- Publication type:
- Article
Epstein–Barr virus early-antigen antibodies before allogeneic haematopoietic stem cell transplantation as a marker of risk of post-transplant lymphoproliferative disorders.
- Published in:
- British Journal of Haematology, 2007, v. 136, n. 2, p. 305, doi. 10.1111/j.1365-2141.2006.06420.x
- By:
- Publication type:
- Article
Comparison of flow cytometry and enzyme cytochemistry for the detection of myeloperoxydase in acute myeloid leukaemia: interests of a new positivity threshold.
- Published in:
- British Journal of Haematology, 2003, v. 122, n. 2, p. 211, doi. 10.1046/j.1365-2141.2003.04384.x
- By:
- Publication type:
- Article
Allogeneic hematopoietic stem cell transplantation for T-prolymphocytic leukemia: a report from the French society for stem cell transplantation ( SFGM- TC).
- Published in:
- European Journal of Haematology, 2015, v. 94, n. 3, p. 265, doi. 10.1111/ejh.12430
- By:
- Publication type:
- Article
CXCR4-Related Increase of Circulating Human Lymphoid Progenitors after Allogeneic Hematopoietic Stem Cell Transplantation.
- Published in:
- PLoS ONE, 2014, v. 9, n. 3, p. 1, doi. 10.1371/journal.pone.0091492
- By:
- Publication type:
- Article
Palivizumab Treatment of Respiratory Syncytial Virus Infection after Allogeneic Hematopoietic Stem Cell Transplantation.
- Published in:
- Clinical Infectious Diseases, 2007, v. 45, n. 8, p. 1019, doi. 10.1086/521912
- By:
- Publication type:
- Article
Primary Epstein-Barr Virus Infection with Pneumonia Transmitted by Allogeneic Bone Marrow after Transplantation.
- Published in:
- Clinical Infectious Diseases, 2006, v. 43, n. 7, p. 892, doi. 10.1086/507034
- By:
- Publication type:
- Article
Haemolytic paroxysmal nocturnal haemoglobinuria in patients with myeloid neoplasms: A rare association with specific therapeutic implications.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 2, p. e16, doi. 10.1111/bjh.18693
- By:
- Publication type:
- Article
Crovalimab for treatment of patients with paroxysmal nocturnal haemoglobinuria and complement C5 polymorphism: Subanalysis of the phase 1/2 COMPOSER study.
- Published in:
- British Journal of Haematology, 2022, v. 198, n. 3, p. e46, doi. 10.1111/bjh.18274
- By:
- Publication type:
- Article
How we('ll) treat paroxysmal nocturnal haemoglobinuria: diving into the future.
- Published in:
- British Journal of Haematology, 2022, v. 196, n. 2, p. 288, doi. 10.1111/bjh.17753
- By:
- Publication type:
- Article
Treatment for pure red cell aplasia after major ABO‐incompatible allogeneic stem cell transplantation: a multicentre study.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 4, p. 814, doi. 10.1111/bjh.17463
- By:
- Publication type:
- Article
Pharmacokinetic and pharmacodynamic effects of ravulizumab and eculizumab on complement component 5 in adults with paroxysmal nocturnal haemoglobinuria: results of two phase 3 randomised, multicentre studies.
- Published in:
- British Journal of Haematology, 2020, v. 191, n. 3, p. 476, doi. 10.1111/bjh.16711
- By:
- Publication type:
- Article
The effect of age in patients with acquired aplastic anaemia treated with immunosuppressive therapy: comparison of Adolescents and Young Adults with children and older adults.
- Published in:
- British Journal of Haematology, 2018, v. 183, n. 5, p. 766, doi. 10.1111/bjh.15650
- By:
- Publication type:
- Article
Recovery of full donor chimerism with ibrutinib therapy in relapsed CLL after allogeneic stem cell transplantation.
- Published in:
- British Journal of Haematology, 2017, v. 176, n. 6, p. 997, doi. 10.1111/bjh.14029
- By:
- Publication type:
- Article